target directory

bht 3021 targets autoimmune responses in type 1 diabetes mellitus by modulating t cell responses to autoantigens such as insulin clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.